144. Lennox-Gastaut syndrome Clinical trials / Disease details

Clinical trials : 101 / Drugs : 68 - (DrugBank : 12) / Drug target genes : 49 - Drug target pathways : 60

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00297349 (ClinicalTrials.gov)	November 2003	24/2/2006	A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures	An Open-label Observation Study of Topiramate Administration as Adjuvant Therapy for Focal Epilepsy, Lennox-Gastaut Syndrome Epileptic Seizures and Generalized Tonoclonic Seizures in Adults and Children Aged 2 Years and Older	Seizures;Epilepsy	Drug: Topiramate	Janssen Cilag Pharmaceutica S.A.C.I., Greece	NULL	Completed	2 Years	N/A	Both	153	N/A	NULL
2	NCT00004776 (ClinicalTrials.gov)	November 1993	24/2/2000	Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome		Lennox-Gastaut Syndrome	Drug: topiramate	National Center for Research Resources (NCRR)	University of California, Los Angeles	Completed	4 Years	30 Years	Both	10	Phase 3	NULL
3	NCT00236756 (ClinicalTrials.gov)	August 1993	7/10/2005	A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome	A Double-Blind Trial of Topiramate in Subjects With Lennox-Gastaut Syndrome.	Epilepsy;Seizures	Drug: topiramate	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	NULL	Completed	12 Months	30 Years	Both	100	Phase 3	NULL